Bionic Enterprises is committed to fast tracking the development and reducing the cost of bringing new, safe and effective medical device products to the market.

We will provide value to our customers by translating a broad range of existing IP, technology and manufacturing know-how into new solutions for chronic health conditions.

BE’s lead device is a superior device for the treatment of advanced Parkinson’s disease (PD) using Deep Brain Stimulation (DBS) technologies. One advantage of this platform is that it is customizable for a range of other neurological disorders including epileptic seizures, pain, and drug- resistant psychiatric disorders as well as other movement disorders.

We will leverage over 30 years of internationally recognised expertise in clinically-focussed medical bionics R&D by working closely with our key partner, the Bionics Institute.